Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi BCS-Based Biowaiver Justification for a Generic Immediate-Release Antihypertensive Tablet
*Corresponding Author: Rabia Ahmed, Department of Pharmaceutics, & Bioavailability and Bioequivalence Research Facility, Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi, Pakistan, Email: rabiaahmed33@gmail.comReceived Date: Jun 02, 2025 / Published Date: Jun 30, 2025
Citation: Rabia A (2025) BCS-Based Biowaiver Justification for a Generic Immediate-Release Antihypertensive Tablet. Clin Pharmacol Biopharm, 14: 585.
Copyright: © 2025 Rabia A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
To read the full article Peer-reviewed Article PDF 
